Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.
Made by combining several emerging technologies, human “bodyoids” could reduce animal testing, improve drug development, and alleviate organ shortages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback